NHLBI Announces Availability of Frequently Asked Questions (FAQs) for RFA-HL-20-017, "Cardiovascular Developmental Biology Data Resource Center (U01 - Clinical Trial Not Allowed)"
Notice NOT-HL-19-716 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 13, 2019 Category: Research Source Type: funding
Notice of Special Interest (NOSI): Biosensors to Detect Exacerbations of Cardiopulmonary Disease
Notice NOT-HL-19-708 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 10, 2019 Category: Research Source Type: funding
Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R21/R33 Clinical Trial Optional)
Funding Opportunity PAR-19-305 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Exploratory/Developmental Phased Innovation (R21/R33) grant applications to facilitate early-stage T1 translation (bench-to-bedside) of discoveries from basic and applied research in aging into novel therapeutics for the prevention and treatment of clinical conditions related to aging and/or multiple chronic conditions in older people (e.g., sarcopenia, heart failure with preserved ejection fraction (HFpEF), immunosenescence, metabolic syndrome, chronic kidney disease). This includes the dev...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 25, 2019 Category: Research Source Type: funding
Notice of Change to Application Due Dates in "RFA-HL-20-004 Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) Research Coordinating Center (U24)"
Notice NOT-HL-19-710 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 24, 2019 Category: Research Source Type: funding
Notice of Change to Application Due Dates in RFA-HL-20-003 "Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) (UG3/UH3 Clinical Trial Optional)"
Notice NOT-HL-19-703 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 24, 2019 Category: Research Source Type: funding
Pediatric Cardiac Genomics Consortium (U01 - Clinical Trial Not Allowed)
Funding Opportunity RFA-HL-20-015 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to invite applications to participate as a Research Center in the Pediatric Cardiac Genomics Consortium (PCGC) (http://www.benchtobassinet.com/). The PCGCs mission is to identify genetic causes of human congenital heart disease (CHD) and to relate genetic variants in patients with CHD to clinical outcomes through collaborative, multi-center studies. The PCGC fosters investigation along the translational spectrum of CHD research through interactions with Cardiovascular Development D...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 6, 2019 Category: Research Source Type: funding
Cardiovascular Developmental Biology Data Resource Center (U01 - Clinical Trial Not Allowed)
The objective of this FOA is to support the development of the Data Resource Center for the basic science component of the NHLBI Bench to Bassinet (B2B) Program. The goal of the Data Resource Center is to accelerate discovery of genetic etiology and biologic pathways associated with cardiovascular development and congenital heart disease by facilitating access to and querying of annotated data from cardiovascular development studies. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 6, 2019 Category: Research Source Type: funding
Notice of Change to AIDS Application Due Dates for PA-18-784 "The Mechanistic Role of the Microbiome in the Pathobiology of Heart, Lung, Blood, and Sleep Diseases (R01 - Clinical Trial Not Allowed")
Notice NOT-HL-19-704 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 6, 2019 Category: Research Source Type: funding
Notice of Participation of the National Center for Advancing Translational Sciences (NCATS) in RFA-HL-20-014 - "Rare Disease Cohorts in Heart, Lung, Blood and Sleep Disorders (UG3/UH3 Clinical Trial Not Allowed)"
Notice NOT-TR-19-022 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 5, 2019 Category: Research Source Type: funding
Immunobiology of Xenotransplantation (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-19-042 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications from institutions to participate in the Immunobiology of Xenotransplantation Cooperative Research Program (IXCRP), for the development of preclinical porcine-to-nonhuman primate (NHP) models of pancreatic islet, kidney, heart, lung, or liver xenotransplantation. The goals of this program are to: (1) delineate the cellular and molecular mechanisms of xenograft rejection and/or the induction of immune tolerance; (2) develop effective strategies to improve xenograft survival; and (...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 30, 2019 Category: Research Source Type: funding
Immunobiology of Xenotransplantation (U19 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-19-043 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications from institutions to participate in the Immunobiology of Xenotransplantation Cooperative Research Program (IXCRP), for the development of preclinical porcine-to-nonhuman primate (NHP) models of pancreatic islet, kidney, heart, lung, or liver xenotransplantation. The goals of this program are to: (1) delineate the cellular and molecular mechanisms of xenograft rejection and/or the induction of immune tolerance; (2) develop effective strategies to improve xenograft survival; and (...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 30, 2019 Category: Research Source Type: funding
Notice of Extension of the Response Date for NOT-HL-19-685 "Request for Information (RFI): Inviting Comments and Suggestions on the Potential Development of a Challenge Prize for Heart Failure Phenotyping"
Notice NOT-HL-19-701 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 8, 2019 Category: Research Source Type: funding
Pre-Submission Technical Assistance Webinar and Frequently Asked Questions for RFA-HL-20-004 "Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) Research Coordinating Center (U24)"
Notice NOT-HL-19-693 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 11, 2019 Category: Research Source Type: funding
Pre-Submission Technical Assistance Webinar and Frequently Asked Questions for RFA-HL-20-003: "Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) (UG3/UH3 Clinical Trial Optional)
Notice NOT-HL-19-692 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 11, 2019 Category: Research Source Type: funding
Rare Disease Cohorts in Heart, Lung, Blood and Sleep Disorders (UG3/UH3 Clinical Trial Not Allowed)
Funding Opportunity RFA-HL-20-014 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to fund research centers that will establish longitudinal cohorts in rare HLBS diseases to investigate unaddressed research questions using epidemiologic study designs and methods that are appropriate for conditions affecting fewer than 200,000 persons in the US. These observational cohort studies should be designed to provide an evidence base for future interventional studies, including clinical trials; for developing better diagnostics than those that are currently available; for answering early translational ques...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 4, 2019 Category: Research Source Type: funding
